Market Overview:
The global remdesivir market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of zoonotic diseases, rising demand for novel antiviral drugs, and growing investments in R&D for the development of new antiviral drugs. Based on type, the global remdesivir market can be segmented into 10 mM*1 mL in DMSO, 5mg, 10mg, 50mg and 100mg. The 10 mM*1 mL in DMSO segment is expected to account for a major share of the global remdesivir market during the forecast period. This can be attributed to its easy availability and low cost as compared to other types of remdesivir formulations. Based on application, the global remdesivir market can be divided into hospital pharmacies, clinics pharmacies/outpatient settings pharmacies (OPDs), drug stores/retail pharmacies and others (includes military hospitals). The hospital pharmacy segment is expected to dominate the global Remdesivir Market during 2018-2030 owing high adoption rates across developed countries such as U.S.
Product Definition:
Remdesivir is a novel experimental antiviral drug being developed by Gilead Sciences for the treatment of Ebola virus disease. It is a nucleoside analogue polymerase inhibitor that inhibits the replication of both single- and double-stranded RNA viruses.
10 mM*1 mL in DMSO:
10-mM is a concentration used in the clinical trials of HIV drugs.
The growth factor in 10 mM*1 mL DMSO is B27 but it can also be replaced with any other appropriate growth factor.
5mg:
5mg is a generic name for the drug. It is also known as lamivudine and sold under brand names include Remdesivir, Epzicom1, Valtrex, and others. The medicine works by slowing down the spread of the virus to reduce viral load.
The medicine was first approved in 2003 in the U.S., but it got its patent only recently (2017). The patent gives exclusive rights to Merck & Co., Inc.
Application Insights:
Based on application, the global remdesivir market is segmented into hospital, clinics and drug stores. The hospital segment dominated the market in 2017 owing to increasing incidence of infectious diseases such as COVID-19. In addition, hospitals form a key distribution channel for drugs due to high patient admissions rates and availability of multiple locations that offer easy access to patients. This factor is expected to fuel demand for remdesivir over the forecast period.
The others application segment includes pharmacies and other healthcare facilities such as diagnostic centers or laboratories that perform desiccation preservation procedures on various pharmaceutical products including vaccines, antibiotics & antimalarials among others drugs commonly sold at these facilities like cough syrups & cold medicines etcetera (OTC).
Regional Analysis:
North America dominated the global remdesivir market in terms of revenue share in 2017. The region is expected to maintain its dominance over the forecast period as well owing to high R&D investments and technological advancements. Moreover, increasing cases of COVID-19 are also anticipated to boost demand for remdesivir products across this region.
Asia Pacific is expected to witness lucrative growth over the forecast period due to rising healthcare expenditure and improving infrastructure in emerging countries such as China, India, South Korea & Japan (CIKM). Furthermore, growing awareness about diseases transmission modes will drive regional product demand further. For instance; In February 2018; a study was published by CDC which stated that from 2014 To 2016; an estimated 1 million people got sick with COVID-19 in U.S.
In addition Remedium Pharmaceuticals Inc.
Growth Factors:
- Increasing incidence of viral infections: The increasing incidence of viral infections is one of the key growth drivers for the remdesivir market. Remdesivir is a potential treatment for various viruses such as Ebola, SARS-CoV, MERS-CoV, and Marburg virus. The increasing prevalence of these viruses is expected to drive the demand for remdesivir in the coming years.
- Rising awareness about remdesivir: There is a growing awareness about the potential benefits offered by remdesivir among healthcare professionals and patients alike. This is likely to boost demand for this drug in the coming years.
- Availability of funding for R&D activities: A number of pharmaceutical companies are actively engaged in R&D activities to develop new drugs that can treat various diseases including Ebola and other viral infections. This has led to an increase in funding available for such initiatives, which is likely to benefit the overall remdesivir market growth over the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Remdesivir Market Research Report
By Type
10 mM*1 mL in DMSO, 5mg, 10mg, 50mg, 100mg
By Application
Hospital, Clinics, Drug Store, Others
By Companies
Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
124
Number of Tables & Figures
87
Customization Available
Yes, the report can be customized as per your need.
Global Remdesivir Market Report Segments:
The global Remdesivir market is segmented on the basis of:
Types
10 mM*1 mL in DMSO, 5mg, 10mg, 50mg, 100mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Drug Store, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Gilead Sciences
- Bright Gene
- Hainan Haiyao
- Kelun Pharma
- Hunan Warrant Pharmaceutical
Highlights of The Remdesivir Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 10 mM*1 mL in DMSO
- 5mg
- 10mg
- 50mg
- 100mg
- By Application:
- Hospital
- Clinics
- Drug Store
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Remdesivir Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Remdesivir is an antiviral medication used to treat chronic hepatitis C. It works by stopping the virus from replicating.
Some of the major players in the remdesivir market are Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Remdesivir Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Remdesivir Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Remdesivir Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Remdesivir Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Remdesivir Market Size & Forecast, 2020-2028
4.5.1 Remdesivir Market Size and Y-o-Y Growth
4.5.2 Remdesivir Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 10 mM*1 mL in DMSO
5.2.2 5mg
5.2.3 10mg
5.2.4 50mg
5.2.5 100mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Drug Store
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Remdesivir Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Remdesivir Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 10 mM*1 mL in DMSO
9.6.2 5mg
9.6.3 10mg
9.6.4 50mg
9.6.5 100mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Drug Store
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 10 mM*1 mL in DMSO
10.6.2 5mg
10.6.3 10mg
10.6.4 50mg
10.6.5 100mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Drug Store
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 10 mM*1 mL in DMSO
11.6.2 5mg
11.6.3 10mg
11.6.4 50mg
11.6.5 100mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Drug Store
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 10 mM*1 mL in DMSO
12.6.2 5mg
12.6.3 10mg
12.6.4 50mg
12.6.5 100mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Drug Store
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 10 mM*1 mL in DMSO
13.6.2 5mg
13.6.3 10mg
13.6.4 50mg
13.6.5 100mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Drug Store
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Remdesivir Market: Competitive Dashboard
14.2 Global Remdesivir Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Gilead Sciences
14.3.2 Bright Gene
14.3.3 Hainan Haiyao
14.3.4 Kelun Pharma
14.3.5 Hunan Warrant Pharmaceutical
